BioCardia (United States)

Intramyocardial Stem Cell Injection in Patients With Ischemic Cardiomyopathy

Adam Williams, Barry Trachtenberg, Darcy L. Velazquez et al. · Circulation Research · 2011 · 317 citations · Full text

Rationale and design of the Transendocardial Injection of Autologous Human Cells (bone marrow or mesenchymal) in Chronic Ischemic Left Ventricular Dysfunction and Heart Failure Secondary to Myocardial Infarction (TAC-HFT) trial: A randomized, double-blind, placebo-controlled study of safety and efficacy

Barry Trachtenberg, Darcy L. Velazquez, Adam Williams et al. · American Heart Journal · 2011 · 133 citations

Regenerative Medicine, Heart Failure Secondary, Heart Failure +10

An Open-Label Dose Escalation Study to Evaluate the Safety of Administration of Nonviral Stromal Cell-Derived Factor-1 Plasmid to Treat Symptomatic Ischemic Heart Failure

Marc S. Penn, Farrell O. Mendelsohn, Gary L. Schaer et al. · Circulation Research · 2013 · 132 citations

Transendocardial autologous bone marrow in chronic myocardial infarction using a helical needle catheter: 1-year follow-up in an open-label, nonrandomized, single-center pilot study (the TABMMI study)

Luís de la Fuente, Simon H. Stertzer, Julio Argentieri et al. · American Heart Journal · 2007 · 58 citations

Percutaneous Coronary Intervention, Tabmmi Study, Bone Marrow Failure +12

The CardiAMP Heart Failure trial: A randomized controlled pivotal trial of high-dose autologous bone marrow mononuclear cells using the CardiAMP cell therapy system in patients with post–myocardial infarction heart failure: Trial rationale and study design

Amish N. Raval, Thomas D. Cook, Henricus J. Duckers et al. · American Heart Journal · 2018 · 26 citations

Pivotal Trial, Heart Failure, Study Design +14